About Us | Privacy | Site Map
February 10, 2012
Font Size
A
A
A

Multiple Sclerosis (cont.)

Medical Author:
Medical Editor:

Authors and Editors

Author: Fernando Dangond, MD, Director, Medical Affairs - Specialized Therapeutics, Bayer HealthCare Pharmaceuticals.

Editor: Melissa Conrad Stöppler, MD

REFERENCE: FDA prescribing information for fingolimod.

Previous contributing authors and editors: Author: Brian C Rich, DO, Consulting Staff, Department of Emergency Medicine, Emergency Services Group. Coauthor(s): Janene Hecker, MD, FACEP, Consulting Staff, Department of Emergency Medicine, Allegheny General Hospital; Assistant Professor, Department of Emergency Medicine, Allegheny University of the Health Sciences. Editors: Scott H Plantz, MD, FAAEM, Research Director, Assistant Professor, Department of Emergency Medicine, Mount Sinai School of Medicine; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Jeter (Jay) Pritchard Taylor III, MD, Vice-Chief, Compliance Officer, Attending Physician Emergency Medicine Residency, Department of Emergency Medicine, Palmetto Richland Memorial Hospital, University of South Carolina.


Last Editorial Review: 11/26/2007

Viewer Comments & Reviews

Multiple Sclerosis - Symptoms at Onset of Disease

The eMedicineHealth physician editors ask:

The symptoms of multiple sclerosis can vary greatly from patient to patient. What were your symptoms at the onset of your disease?

Multiple Sclerosis - Effective Treatment

The eMedicineHealth physician editors ask:

What treatment has been effective for your multiple sclerosis?

Multiple Sclerosis

Get the latest treatment options.




Read What Your Physician is Reading on Medscape

Multiple Sclerosis »

Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS).

Read More on Medscape Reference »

Medical Dictionary


Use Pill Finder Find it Now

Pill Identifier on RxList

  • quick,
    easy,
    pill identification

Find a Local Pharmacy

  • including
    24 hour
    pharmacies